Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

Related Articles by Review for PubMed (Select 1352677)

1.
2.

Utilization of radioligands in schizophrenia research.

Sedvall G, Farde L, Hall H, Halldin C, Karlsson P, Nordström AL, Nyberg S, Pauli S.

Clin Neurosci. 1995;3(2):112-21. Review.

PMID:
7583617
4.

Clozapine and D1/D2 antagonism in extrapyramidal functions.

Gerlach J, Hansen L.

Br J Psychiatry Suppl. 1992 May;(17):34-7. Review.

PMID:
1418886
5.

Implications of brain imaging for the management of schizophrenia.

Nyberg S, Nilsson U, Okubo Y, Halldin C, Farde L.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S15-20. Review.

PMID:
9690965
6.

Recent developments in PET scan imaging of neuroreceptors in schizophrenia.

Sedvall G, Pauli S, Farde L, Karlsson P, Nyberg S, Nordström AL.

Isr J Psychiatry Relat Sci. 1995;32(1):22-9. Review.

PMID:
7622344
7.

PET imaging of dopamine receptors in human basal ganglia: relevance to mental illness.

Sedvall G.

Trends Neurosci. 1990 Jul;13(7):302-8. Review.

PMID:
1695408
8.

Atypical antipsychotics: mechanism of action.

Seeman P.

Can J Psychiatry. 2002 Feb;47(1):27-38. Review.

PMID:
11873706
9.

The current status of PET scanning with respect to schizophrenia.

Sedvall G.

Neuropsychopharmacology. 1992 Aug;7(1):41-54. Review.

PMID:
1388021
10.

Antipsychotic occupancy of dopamine receptors in schizophrenia.

Nord M, Farde L.

CNS Neurosci Ther. 2011 Apr;17(2):97-103. doi: 10.1111/j.1755-5949.2010.00222.x. Epub 2010 Dec 8. Review.

PMID:
21143431
11.
12.

[Receptor occupancy and antipsychotic drug action measured by PET and SPECT].

Okubo Y, Suhara T.

Seishin Shinkeigaku Zasshi. 2001;103(4):329-40. Review. Japanese.

PMID:
11392846
13.

Mechanism of new antipsychotic medications: occupancy is not just antagonism.

Grunder G, Carlsson A, Wong DF.

Arch Gen Psychiatry. 2003 Oct;60(10):974-7. Review.

PMID:
14557141
14.

Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.

Kasper S, Tauscher J, Willeit M, Stamenkovic M, Neumeister A, Küfferle B, Barnas C, Stastny J, Praschak-Rieder N, Pezawas L, de Zwaan M, Quiner S, Pirker W, Asenbaum S, Podreka I, Brücke T.

World J Biol Psychiatry. 2002 Jul;3(3):133-46. Review.

PMID:
12478878
15.

Estimating dopamine D₂ receptor occupancy for doses of 8 antipsychotics: a meta-analysis.

Lako IM, van den Heuvel ER, Knegtering H, Bruggeman R, Taxis K.

J Clin Psychopharmacol. 2013 Oct;33(5):675-81. doi: 10.1097/JCP.0b013e3182983ffa. Review.

PMID:
23948784
16.

[Atypical neuroleptics, pharmacology and clinical importance].

Klages U, Hippius H, Müller-Spahn F.

Fortschr Neurol Psychiatr. 1993 Nov;61(11):390-8. Review. German.

PMID:
7903656
17.

Pharmacotherapy of schizophrenia in Germany.

Bartels M.

Keio J Med. 1992 Jun;41(2):59-63. Review.

18.
19.

New insights into the biology of schizophrenia through the mechanism of action of clozapine.

Brunello N, Masotto C, Steardo L, Markstein R, Racagni G.

Neuropsychopharmacology. 1995 Nov;13(3):177-213. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk